Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for 688108.SS and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 688108.SS and 80,000+ other tickers.
See exactly how 688108.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 688108.SS and 80,000+ other tickers.
Sino Medical Sciences Technology Inc. operates as a medical device enterprise, specializing in the research, development, manufacturing, and distribution of interventional medical devices throughout China. Its product portfolio features a range of crucial items, including drug-eluting stents, balloon catheters, coronary stents, and sophisticated transcatheter mitral valve replacement devices. Furthermore, the company maintains a clinical partnership with The National University of Ireland Galway. Established in 2007, its main operational base is situated in Tianjin, China.
No recent news available.